Cancers’ sweet tooth may be weakness

(Emory University) Cancer cells tend to take up more glucose than healthy cells and metabolize it in a process called glycolysis. An enzyme called PKM2 that governs cancer cells’ preference for glucose may be a valuable anti-cancer drug target.

source : www.eurekalert.org

Related News:

• Road Mapping Could Be Key To Curing TB
• Even Normal Glucose in Kids Could Predict Diabetes Later (CME/CE)
• Mechanical Forces Could Affect Gene Expression
• Placental Infection Could Spur Asthma (CME/CE, with audio)
• Early Intervention Could Prevent Schizophrenia
• Research Breakthrough Could Lead To New Treatment For Malaria
• UCF professor’s vaccine could be lethal weapon against malaria, cholera
• Global supply of rare earth elements could be wiped out by 2012
• Surprising Discovery Could Help Scientists Refine Treatment For Advanced Melanoma
• Llama proteins could play a vital role in the war on terror

Details :
Submited at Wednesday, November 18th, 2009 at 1:00 pm on Cancer and Oncology by jessica
Comment RSS 2.0 - leave a comment - trackback